These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 19786391)

  • 21. X-PERT: weight reduction with orlistat in obese subjects receiving a mildly or moderately reduced-energy diet: early response to treatment predicts weight maintenance.
    Toplak H; Ziegler O; Keller U; Hamann A; Godin C; Wittert G; Zanella MT; Zúñiga-Guajardo S; Van Gaal L
    Diabetes Obes Metab; 2005 Nov; 7(6):699-708. PubMed ID: 16219013
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety comparative evaluation of orlistat and sibutramine treatment in hypertensive obese patients.
    Derosa G; Cicero AF; Murdolo G; Piccinni MN; Fogari E; Bertone G; Ciccarelli L; Fogari R
    Diabetes Obes Metab; 2005 Jan; 7(1):47-55. PubMed ID: 15642075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The cerebrospinal fluid/serum leptin ratio during pharmacological therapy for obesity.
    Rodrigues AM; Radominski RB; Suplicy Hde L; De Almeida SM; Niclewicz PA; Boguszewski CL
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1621-6. PubMed ID: 11932292
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The relationship of excess body weight and health-related quality of life: evidence from a population study in Taiwan.
    Huang IC; Frangakis C; Wu AW
    Int J Obes (Lond); 2006 Aug; 30(8):1250-9. PubMed ID: 16520814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Weight loss intervention for obese older women: improvements in performance and function.
    Jensen GL; Roy MA; Buchanan AE; Berg MB
    Obes Res; 2004 Nov; 12(11):1814-20. PubMed ID: 15601977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Health-related quality of life in obese outpatients losing weight with very-low-energy diet and behaviour modification: a 2-y follow-up study.
    Kaukua J; Pekkarinen T; Sane T; Mustajoki P
    Int J Obes Relat Metab Disord; 2003 Sep; 27(9):1072-80. PubMed ID: 12917713
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of sibutramine-induced weight loss on cardiovascular system in obese subjects.
    de Simone G; Romano C; De Caprio C; Contaldo F; Salanitri T; di Luzio Paparatti U; Pasanisi F
    Nutr Metab Cardiovasc Dis; 2005 Feb; 15(1):24-30. PubMed ID: 15871847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of sibutramine in overweight adult hispanic patients with type 2 diabetes mellitus: a 12-month, randomized, double-blind, placebo-controlled clinical trial.
    Sánchez-Reyes L; Fanghänel G; Yamamoto J; Martínez-Rivas L; Campos-Franco E; Berber A
    Clin Ther; 2004 Sep; 26(9):1427-35. PubMed ID: 15531005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nonrandomized trial of weight loss with orlistat, nutrition education, diet, and exercise in obese patients with CKD: 2-year follow-up.
    MacLaughlin HL; Cook SA; Kariyawasam D; Roseke M; van Niekerk M; Macdougall IC
    Am J Kidney Dis; 2010 Jan; 55(1):69-76. PubMed ID: 19926371
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Weight loss in obese Mexican Americans treated for 1-year with orlistat and lifestyle modification.
    Poston WS; Reeves RS; Haddock CK; Stormer S; Balasubramanyam A; Satterwhite O; Taylor JE; Foreyt JP
    Int J Obes Relat Metab Disord; 2003 Dec; 27(12):1486-93. PubMed ID: 14634679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of sibutramine to assist obese women with weight loss can be successful in dietitian-led clinics: another tool in the dietitian's toolbox.
    Barratt R; Frost G; O'Boyle A; Millward J; Truby H
    J Hum Nutr Diet; 2008 Jun; 21(3):248-55. PubMed ID: 18477180
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The new role of pharmacotherapy for weight reduction in obesity.
    Fernstrom MH; Fernstrom JD
    Int J Clin Pract; 2002 Nov; 56(9):683-6. PubMed ID: 12469983
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the effects of sibutramine and orlistat on obese, poorly-controlled type 2 diabetic patients.
    Chou KM; Huang BY; Fanchiang JK; Chen CH
    Chang Gung Med J; 2007; 30(6):538-46. PubMed ID: 18350737
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of weight reduction by sibutramine on female sexual function.
    Kim KK; Kang HC; Kim SS; Youn BB
    Int J Obes (Lond); 2006 May; 30(5):758-63. PubMed ID: 16404407
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Health-related quality of life and weight loss among overweight and obese U.S. adults, 2001 to 2002.
    Bish CL; Michels Blanck H; Maynard LM; Serdula MK; Thompson NJ; Kettel Khan L
    Obesity (Silver Spring); 2006 Nov; 14(11):2042-53. PubMed ID: 17135622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of response to sibutramine therapy in obese non-diabetic and diabetic patients.
    Finer N; Ryan DH; Renz CL; Hewkin AC
    Diabetes Obes Metab; 2006 Mar; 8(2):206-13. PubMed ID: 16448525
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term weight loss decreases the nontraditional cardiovascular risk factors interleukin-18 and matrix metalloproteinase-9 in obese subjects.
    Madsen EL; Bruun JM; Skogstrand K; Hougaard DM; Christiansen T; Richelsen B
    Metabolism; 2009 Jul; 58(7):946-53. PubMed ID: 19409578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of weight loss and regain on quality of life: mirror image or differential effect?
    Engel SG; Crosby RD; Kolotkin RL; Hartley GG; Williams GR; Wonderlich SA; Mitchell JE
    Obes Res; 2003 Oct; 11(10):1207-13. PubMed ID: 14569046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial.
    Harrison SA; Fecht W; Brunt EM; Neuschwander-Tetri BA
    Hepatology; 2009 Jan; 49(1):80-6. PubMed ID: 19053049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term pharmacotherapy for obesity.
    Klein S
    Obes Res; 2004 Dec; 12 Suppl():163S-6S. PubMed ID: 15687412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.